Neuroscience News and Research

RSS

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

UT Southwestern Medical Center has launched a state-of-the-art telemedicine program that will extend immediate access to UT Southwestern's nationally recognized stroke care during the crucial time period when treatment is needed for a patient of an ischemic stroke, or clot in one of the brain's blood vessels.

1 Apr 2014

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Binghamton University was recently awarded a HEARTSafe Campus accreditation from the National Collegiate Emergency Medical Services Foundation, making Binghamton one of only five colleges and universities in the United States and Canada to achieve the accreditation.

1 Apr 2014

Otsuka acquires rights to develop and sell Eisai’s DACOGEN in the US, Canada and Japan

Eisai Inc., a subsidiary of Tokyo-based Eisai Co., Ltd., today announced the sale and assignment of its rights to a worldwide exclusive license for DACOGEN® (decitabine) for Injection to Otsuka Pharmaceutical Co., Ltd., giving Otsuka full development and commercialization rights for the product in the former Eisai territories of the United States, Canada and Japan.

31 Mar 2014

Potassium boost improves walking, prolongs survival in mouse model of Huntington's disease

Tweaking a specific cell type's ability to absorb potassium in the brain improved walking and prolonged survival in a mouse model of Huntington's disease, reports a UCLA study published March 30 in the online edition of Nature Neuroscience. The discovery could point to new drug targets for treating the devastating disease, which strikes one in every 20,000 Americans.

31 Mar 2014

Einstein faculty members present recent research at AACR Annual Meeting

From uncovering the role nerve cells play in metastasis to identifying new cancer-causing genes, researchers at Albert Einstein College of Medicine of Yeshiva University made notable advances in the understanding and potential treatment of cancer during the past year.

29 Mar 2014

Johns Hopkins neuroscientists identify cause of brain degeneration in Huntington's disease

Working with genetically engineered mice, Johns Hopkins neuroscientists report they have identified what they believe is the cause of the vast disintegration of a part of the brain called the corpus striatum in rodents and people with Huntington's disease: loss of the ability to make the amino acid cysteine.

29 Mar 2014

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the launch of Schizophrenia Research: Cognition, a new open access journal dedicated to publishing original research, concise research reports, brief reports, letters to the editor, and review papers addressing the role of cognitive functioning in schizophrenia.

28 Mar 2014

Early life chronic stress may cause anxiety in adulthood, says study

In recent years, behavioral neuroscientists have debated the meaning and significance of a plethora of independently conducted experiments seeking to establish the impact of chronic, early-life stress upon behavior - both at the time that stress is experienced, and upon the same individuals later in life, during adulthood.

28 Mar 2014

Schizophrenia Research: Cognition, an online open access journal from Elsevier

27 Mar 2014

New drug multiplies analgesic effect of opioids without increasing constipation

Scientists from the University of Granada have taken part, alongside the Esteve laboratory, in the development of a new drug that multiplies the analgesic effect of opioids (drugs for treating intense pain), without increasing constipation, one of the most common side-effects of these drugs, among which is morphine.

27 Mar 2014

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.

27 Mar 2014

Personalis and Inova team up to advance genomic medicine

Inova Translational Medicine Institute and Personalis, Inc. today announced a partnership to advance genomic medicine for Inova's patient population.

27 Mar 2014

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Migraine sufferers who experienced reduced stress from one day to the next are at significantly increased risk of migraine onset on the subsequent day, according to a new study conducted by researchers at the Montefiore Headache Center and Albert Einstein College of Medicine at Yeshiva University.

27 Mar 2014

Scientists discover why cerebellar granule cell neurons in A-T patients fail to repair DNA damage

A team of scientists, led by Stuart Lipton, M.D., Ph.D., professor and director of the Neuroscience and Aging Research Center at Sanford-Burnham Medical Research Institute, recently discovered why cerebellar granule cell neurons in patients suffering from ataxia-telangiectasia (A-T) were unable to repair DNA damage and thus died.

26 Mar 2014

Research findings point to potential biomarkers for early detection of at-risk youth

Researchers at the University of California, San Diego School of Medicine have discovered impaired neuronal activity in the parts of the brain associated with anticipatory functioning among occasional 18- to 24-year-old users of stimulant drugs, such as cocaine, amphetamines and prescription drugs such as Adderall.

26 Mar 2014

Bielefeld neuroscientists present a new bodily illusion

To induce an illusory perception of the material properties of the hand, a group of neuroscientists from Bielefeld University, the Max-Planck Institute for Biological Cybernetics (Germany), and the University of Milano-Bicocca (Italy) asked volunteers to sit with their hands lying on a table in front of them.

25 Mar 2014

New subcellular mechanism identified for fast transmission in basket cells of the brain

In his third major research paper since December 2013, IST Austria Professor Peter Jonas together with his collaborator, postdoc Hua Hu, identifies a new subcellular mechanism for reliable, fast transmission in the so-called basket cells of the brain.

25 Mar 2014

Anxiety relief in children: an interview with Dr. Golda Ginsburg, Johns Hopkins Children’s Center

Anxiety is the most common psychiatric disorder among youth. Prevalence rates hover around 10%, although the actual percent varies depending on the specific anxiety disorder, sample, method of assessment, etc.

24 Mar 2014

New book "Near-Death Experiences" explores controversial topic with historical reports

In popular understanding, the expression "near-death experience" refers to the transition between the states of life and death. But how should such experiences be interpreted? Are they verifiable with scientific methods? If so, how can they be explained? Attempting to relate matters of scientific knowledge to subjective experience and the realm of belief is a difficult balancing act, and has led to a variety of approaches to the topic.

24 Mar 2014

New treatment could halt progression of dementia

Researchers at the University of Texas Medical Branch at Galveston have discovered a way to potentially halt the progression of dementia caused by accumulation of a protein known as tau.

21 Mar 2014

Neuroscience News and Research

UT Southwestern launches telemedicine program to extend stroke care to patients in rural areas

Binghamton University receives HEARTSafe Campus accreditation from NCEMSF

Otsuka acquires rights to develop and sell Eisai’s DACOGEN in the US, Canada and Japan

Potassium boost improves walking, prolongs survival in mouse model of Huntington's disease

Einstein faculty members present recent research at AACR Annual Meeting

Johns Hopkins neuroscientists identify cause of brain degeneration in Huntington's disease

Elsevier launches open access journal addressing role of cognitive functioning in schizophrenia

Early life chronic stress may cause anxiety in adulthood, says study

Schizophrenia Research: Cognition, an online open access journal from Elsevier

New drug multiplies analgesic effect of opioids without increasing constipation

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

Personalis and Inova team up to advance genomic medicine

Study highlights importance of stress management, healthy lifestyle habits for people with migraine

Scientists discover why cerebellar granule cell neurons in A-T patients fail to repair DNA damage

Research findings point to potential biomarkers for early detection of at-risk youth

Bielefeld neuroscientists present a new bodily illusion

New subcellular mechanism identified for fast transmission in basket cells of the brain

Anxiety relief in children: an interview with Dr. Golda Ginsburg, Johns Hopkins Children’s Center

New book "Near-Death Experiences" explores controversial topic with historical reports

New treatment could halt progression of dementia

Event guide: 2nd Neuroscience Innovation Partnering & Licensing Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News